Insider Transactions in Q1 2021 at Entasis Therapeutics Holdings Inc. (ETTX)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Jan 15 2021	John Patrick Mueller Chief Development Officer	BUY Grant, award, or other acquisition	Direct	25,000 +50.0%	-
Jan 15 2021	David Altarac Chief Medical Officer	BUY Grant, award, or other acquisition	Direct	25,000 +50.0%	-
Jan 15 2021	Elizabeth M Keiley General Counsel	BUY Grant, award, or other acquisition	Direct	25,000 +50.0%	-
Jan 15 2021	Manoussos Perros President and CEO	BUY Grant, award, or other acquisition	Direct	79,750 +50.0%	-
Jan 15 2021	Matthew Ronsheim Chief of Pharma Sciences & MFG	BUY Grant, award, or other acquisition	Direct	25,000 +50.0%	-
Jan 15 2021	Michael Gutch Officer	BUY Grant, award, or other acquisition	Direct	25,000 +50.0%	-
Jan 15 2021	Ruben Tommasi Chief Scientific Officer	BUY Grant, award, or other acquisition	Direct	25,000 +34.71%	-

Receive a notification when an Institution or Guru buys or sells ETTX shares.

Notify only if

Value

Get notified when an Entasis Therapeutics Holdings Inc. insider buys or sells ETTX shares.

Notify only if

Operation

Value

Type

Receive news related to Entasis Therapeutics Holdings Inc.